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22S Abstracts May Supplement 2013Results: The 30-day mortality rate was 4.7% (4/86);
patient survival was 88% at 1 year and 85% at 2 years.
From baseline to 2 years (Fig), the true lumen diameter
increased signiﬁcantly in the descending thoracic aorta
(DTA) and the more distal abdominal aorta (AA), with
a concomitant decrease in false lumen diameter. Trans-
aortic growth (>5 mm) occurring at any time within 2
years was observed in the DTA in 21 patients and in
the AA in 21 patients; a majority of these patients had
acute dissection (17/21 for DTA, 20/21 for AA).
Mortality, rupture, conversion, and secondary interven-
tion were not signiﬁcantly different between patients
with and without transaortic growth. A generalized linear
model indicates that a shorter time from symptom onset
to treatment predicts transaortic growth in both the
DTA (P ¼ .03) and AA (P < .001), and a higher SVS
risk score for hypertension predicts growth in the AA
(P ¼ .04).
Conclusions: Endovascular repair of cTBAD using
a composite construct demonstrates favorable aortic
remodeling. However, patients treated in the acute setting
may be prone to aortic growth and require close observa-
tion. Follow-up through 5 years is ongoing.Fig. Maximum diameters of the true lumen, false lumen, and total
lumen in the descending thoracic aorta (DTA) and abdominal aorta
(AA) (least square means estimated from a general linear model).
The increase in true lumen size and decrease in false lumen size
were statistically signiﬁcant in both aortic segments from pre-
procedure to 2 years (P < 0.001). Number of patients with avail-
able total lumen measurements is indicated for each time point.
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Anatomical Feasibility of Off-the-Shelf Fenestrated
Stent Grafts to Treat Juxtarenal and Pararenal
Abdominal Aortic Aneurysms
Bernardo Mendes, Gustavo S. Oderich, Stephen Cha,
Audra A. Duncan, Manju Kalra, Mark Fleming, Peter
Gloviczki, Thanila Macedo, Thomas C. Bower. Division
of Vascular and Endovascular Surgery, Mayo Clinic,
Rochester, Minn
Objectives: To evaluate the anatomical feasibility of
two off-the-shelf fenestrated stent-grafts to treat juxtarenal
(JRA) and pararenal (PRA) abdominal aortic aneurysms
(AAAs).
Methods: Digital computed tomography angiography
was analyzed in 520 consecutive patients treated with open
or fenestrated endovascular repair for complex AAAs
between 2000-2012. The anatomical feasibility of two
off-the-shelf fenestrated designs - Endologix Ventana
(Irvine, California) and Cook p-Branch (Brisbane,
Australia) - was analyzed using Instructions for Use
(IFU) proposed by investigational protocols.t renal) dots indicate location of each artery in relation to
y. The blue-shaded area indicates range of visceral artery
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Volume 57, Number 5S Abstracts 23SResults: There were 390 patients (75%) with JRA/
PRAs considered potential candidates for the two devices.
Proximal seal (>15 mm) could be achieved in all patients
using p-Branch and in 61% of the patients using Ven-
tana stent-graft (P < .0001). The ability to incorporate
visceral arteries (Fig) was greater using Ventana (90%)
compared to p-Branch (61%; P < .0001) design. Less
than a third of patients met strict IFU criteria for using
Ventana (25%) or p-Branch (32%; P < .05) devices.
Using liberal IFU criteria, 42% of patients were candidates
for Ventana and 49% for p-Branch (P < .03). Overall
63% of the patients with JRA/PRAs were candidates for
endovascular repair using one of the two devices.
Conclusions: p-Branch design has greater anatom-
ical feasibility and achieves proximal seal in all patients
with JRA/PRAs, but is not able to incorporate visceral
arteries in 40% of patients. Ventana design allows incor-
poration of the visceral arteries in 90% of patients, but fails
to provide sufﬁcient seal in 40%. Nearly 40% of JRA/PRAs
do not meet anatomical criteria for endovascular repair
using one the two devices, justifying need for additional
designs.
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Smooth Muscle Cells from Abdominal Aortic
Aneurysms Are Unique and Can Independently and
Synergistically Degrade Insoluble Elastin
Nathan D. Airhart, Bernard Brownstein, William
Schierding, Perren Cobb, Batool Arif, Terri Ennis,
Robert Thompson, John A. Curci. Surgery, Washington
University School of Medicine, St Louis, Mo
Objectives: The purpose of this study was to further
elucidate the role of the vascular smooth muscle cell
(SMC) in abdominal aortic aneurysm (AAA) disease. Our
hypothesis is that AAA-SMC are unique and actively partic-
ipate in the process of degrading the aortic matrix.
Methods: Using microarray, we compared whole-
genome expression proﬁles of SMC from AAA, normal
abdominal aorta (NAA) and carotid endarterectomy
(CEA). We quantiﬁed elastolytic activity by culturing
SMC in [3H] elastin-coated plates and measuring solubi-
lized tritium in the media after 7 days. MMP-2 and
MMP-9 production was assessed using real-time PCR,
zymography and western blotting.
Results: Uniquegene expressionpatternswereobserved
for each SMC type. Under basal conditions, AAA-SMC had
much greater elastolytic activity than NAA (+68%; P <
.001) and CEA-SMC (+45%; P < .001). Zymographyshowed a relative increase of active-MMP-2 (62kD) in media
from AAA-SMC. AAA-SMC demonstrated 2 fold greater
expression of MMP-2 mRNA (P < .05) and 7.3 fold greater
MMP-9 expression (P< .01) than NAA-SMC. Culture with
activatedU937monocytes led to a synergistic increase in elas-
tolytic activity by AAA-SMC (41%; P< .001). This effect was
not apparent in NAA or CEA co-cultures (P ¼ .99). Co-
culture with U937 led to a large increase in MMP-9 mRNA
in both AAA and NAA-SMC (P < .001). MMP-2 mRNA
expression was not affected. Western blots of conditioned
media showed increased MMP-9 (92 kD) protein secretion
by AAA-SMC/U937 cultures which was approximately 4-
fold greater than NAA-SMC/U937 (P < .001). AAA-
SMC/U937 co-cultures also exhibited a large increase in
active-MMP2 (62 kD) in conditionedmedia, an effect which
was much less apparent in NAA/U937 media (P < .01).
Conclusions: AAA-SMC exhibit a unique gene
expression pattern and have a pro-elastolytic phenotype
that is augmented by macrophages. This may occur via
a failure of post-transcriptional control of MMP-9 protein
synthesis, leading to increased production and activation
of elastolytic MMPs.
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Five Years Results of Aortic Arch Debranching
Paola De Rango2, Ciro Ferrer1, Carlo Coscarella1, Gioele
Simonte2, Enrico Cieri2, Luca Farchioni2, Fabio Verzini2,
Gianbattista Parlani2, Piergiorgio Cao1. 1Vascular
Surgery, Hospital S Camillo Forlanini, Rome, Italy;
2Vascular and Endovascular Surgery; University of
Perugia, Hospital S.M.Misericordia, Perugia, Italy
Objectives: To evaluate early and ﬁve years results of
partial or total arch debranching.
Methods: In 2001-2012, 100 consecutive patients
underwent elective hybrid arch repair with debranching
and stentgraft (TEVAR). Outcomes were stratiﬁed for
extension of arch involvement. Primary outcomes were
perioperative (30-day) and ﬁve years mortality.
Results: Mean patients age was 70.1years and 88 were
males. 16 archeswere repaired for dissection.Twenty patients
required total debranching for diseases extended to Zone-0.
In 55, debranching and TEVAR procedures were staged.
At 30-day, death, stroke and paraplegia occurred in 6, 4
and 3 patients respectively. In 80, requiring partial debranch-
ing, the same outcome rates were 2.5%, 3.8% and 2.5%,
respectively. In patients with dissections, there was no death,
paraplegia or stroke. Extension to ascending aorta requiring
total arch debranching was the only multivariate indepen-
dent predictor for mortality (odds ratio, 11.4; 95% Conﬁ-
dence Interval 1.91-68.4; P ¼ .008), but not for stroke
or paraplegia. One retrograde dissection with successful
repair, occurred after total debranching. Kaplan-Meier
